Trial Outcomes & Findings for Implementation of Nasal Non-Invasive Ventilation With a RAM Cannula in the Inpatient /Outpatient Setting (NCT NCT03473171)

NCT ID: NCT03473171

Last Updated: 2020-03-24

Results Overview

Complications include respiratory failure, tachypnea, hypercapnia, hypoxemia, air trapping or hyperexpansion.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

5 participants

Primary outcome timeframe

7 days after starting the RAM cannula

Results posted on

2020-03-24

Participant Flow

Participant milestones

Participant milestones
Measure
Nasal Non-invasive Ventilation With RAM Cannula
Nasal non-invasive ventilation with RAM cannula: Pediatric Pulmonary Team will be consulted on inpatient or outpatient patients that fail to wean from chronic respiratory support (CPAP, BiPAP, High flow Nasal Cannula) in whom long-term ventilation is considered. Pediatric Pulmonary Team, as a consultant, will consider patient history, physical examination, previous imaging and laboratories and previous attempts to wean from respiratory support and causes of failure to wean. The Pulmonary team will determine which patients would potentially benefit from use of NIV/RAM-NC for long-term respiratory support and will recommend initiation of NIV/RAM-NC.
Overall Study
STARTED
5
Overall Study
COMPLETED
5
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Implementation of Nasal Non-Invasive Ventilation With a RAM Cannula in the Inpatient /Outpatient Setting

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Nasal Non-invasive Ventilation With RAM Cannula
n=5 Participants
Nasal non-invasive ventilation with RAM cannula: Pediatric Pulmonary Team will be consulted on inpatient or outpatient patients that fail to wean from chronic respiratory support (CPAP, BiPAP, High flow Nasal Cannula) in whom long-term ventilation is considered. Pediatric Pulmonary Team, as a consultant, will consider patient history, physical examination, previous imaging and laboratories and previous attempts to wean from respiratory support and causes of failure to wean. The Pulmonary team will determine which patients would potentially benefit from use of NIV/RAM-NC for long-term respiratory support and will recommend initiation of NIV/RAM-NC.
Age, Continuous
5.92 years
STANDARD_DEVIATION 7.75 • n=99 Participants
Sex: Female, Male
Female
3 Participants
n=99 Participants
Sex: Female, Male
Male
2 Participants
n=99 Participants
Race/Ethnicity, Customized
African American
3 Participants
n=99 Participants
Race/Ethnicity, Customized
Caucasian
1 Participants
n=99 Participants
Race/Ethnicity, Customized
Hispanic
1 Participants
n=99 Participants
Region of Enrollment
United States
5 Participants
n=99 Participants

PRIMARY outcome

Timeframe: 7 days after starting the RAM cannula

Complications include respiratory failure, tachypnea, hypercapnia, hypoxemia, air trapping or hyperexpansion.

Outcome measures

Outcome measures
Measure
Nasal Non-invasive Ventilation With RAM Cannula
n=5 Participants
Nasal non-invasive ventilation with RAM cannula: Pediatric Pulmonary Team will be consulted on inpatient or outpatient patients that fail to wean from chronic respiratory support (CPAP, BiPAP, High flow Nasal Cannula) in whom long-term ventilation is considered. Pediatric Pulmonary Team, as a consultant, will consider patient history, physical examination, previous imaging and laboratories and previous attempts to wean from respiratory support and causes of failure to wean. The Pulmonary team will determine which patients would potentially benefit from use of NIV/RAM-NC for long-term respiratory support and will recommend initiation of NIV/RAM-NC.
Feasibility as Assessed by Number of Participants Who Had Complications
0 Participants

Adverse Events

Nasal Non-invasive Ventilation With RAM Cannula

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

James M. Stark, MD

The University of Texas Health Science Center at Houston

Phone: 713-500-5650

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place